NIH-funded research R01 grant

The link between gut bacteria and early death in dialysis patients

Official title: Circulating microbiome and premature mortality in hemodialysis patients

Funded at University of Tennessee Health Sci Ctr · NIH-10793526 · Data updated 2026-11-12

This study is looking at how certain germs in the blood might affect inflammation and the risk of early death in people on hemodialysis, helping us understand their impact on heart health and overall well-being.

More Premature research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Tennessee Health Sci Ctr
NIH-funded
Lab location1 site (Memphis, United States)
Project startJuly 1, 2020
Project endFebruary 28, 2026
Funding year2024
Award (this year)$359,704
NIH project number5R01DK125586-05
Project IDNIH-10793526 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients with end-stage renal disease who are currently receiving hemodialysis treatment.

Less likely to help

Patients who are not undergoing hemodialysis or those with acute infections may not benefit from this research.

What this research studies

This research investigates how the presence of certain microorganisms in the bloodstream may contribute to chronic inflammation and increased risk of premature death in patients undergoing hemodialysis. By analyzing the circulating microbiome, which includes bacteria, archaea, and fungi, the study aims to understand its relationship with cardiovascular diseases and overall health outcomes in end-stage renal disease (ESRD) patients. The approach involves advanced microbial DNA sequencing to identify and quantify these microorganisms over time, providing insights into their potential role in inflammation and mortality.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for reducing inflammation and improving survival rates in hemodialysis patients.

How similar studies have gone: While the concept of the circulating microbiome is relatively novel, previous studies have shown promising results linking microbial communities to chronic inflammation and cardiovascular conditions.

Where this research is happening

  • University of Tennessee Health Sci Ctr
    Memphis, United States
    Active

Researchers

  • Principal investigator: Sumida, Keiichi — University of Tennessee Health Sci Ctr
  • Study coordinator: Sumida, Keiichi

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.